FDA Commissioner Gottlieb Resigning Effective in April

FDA Commissioner Gottlieb Resigning Effective in April

Gottlieb said he is leaving to spend more time with his family.

Subscribe
March 6, 2019

The Hill – FDA Commissioner Scott Gottlieb is resigning his position effective next month, the Trump administration announced Tuesday. In a note to FDA staff, Gottlieb said he was leaving to spend more time with his family, The Hill report said.

"There's nothing that could pull me away from this role other than the challenge of being apart from my family for these past two years and missing my wife and two young children," he wrote.  

Gottlieb’s resignation was unexpected, and his replacement has not been announced. This was Gottlieb’s second stint at FDA. He served as a deputy FDA commissioner under former President George W. Bush before leaving the agency in 2007.

In his resignation letter, Gottlieb listed a host of agency accomplishments under his tenure, including a record number of generic drug approvals. He lavished praise on agency staff for being able to avert drug and device shortages in the aftermath of Hurricane Maria in Puerto Rico.

Read the full story at The Hill.